{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:50:11Z","timestamp":1758120611977},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,12,1]]},"DOI":"10.1095\/biolreprod.102.006478","type":"journal-article","created":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T18:30:50Z","timestamp":1098297050000},"page":"1959-1974","source":"Crossref","is-referenced-by-count":17,"title":["Structural Requirements for Potent Anti-Human Immunodeficiency Virus (HIV) and Sperm-Immobilizing Activities of Cyclohexenyl Thiourea and Urea Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase1"],"prefix":"10.1093","volume":"67","author":[{"given":"Osmond J.","family":"D'Cruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taracad K.","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjive","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih M.","family":"Uckun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t20170224154847_R1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(96)01029-X","article-title":"Global burden of the HIV pandemic","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170224154847_R2","first-page":"1","article-title":"HIV\/AIDS Surveillance Report","volume":"12","author":"Centers for Disease Control and Prevention (CDC)","year":"2000"},{"key":"key\n\t\t\t\t20170224154847_R3","article-title":"Report on the Global HIV\/AIDS Epidemic","author":"UNAIDS","year":"2001"},{"key":"key\n\t\t\t\t20170224154847_R4","article-title":"National Institute of Allergy and Infectious Diseases Fact Sheet","author":"HIV Infection in Women","year":"2001"},{"key":"key\n\t\t\t\t20170224154847_R5","first-page":"35","article-title":"Women & HIV. Adolescent sexuality, gender, and the HIV epidemic","volume":"14","year":"2001","journal-title":"BETA"},{"key":"key\n\t\t\t\t20170224154847_R6","first-page":"2S8","article-title":"An overview of the global HIV\/AIDS epidemic, with a focus on the United States","volume":"14","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170224154847_R7","first-page":"52","article-title":"HIV\/AIDS: impact on the African American community","volume":"22","year":"2001","journal-title":"Compend Contin Educ Dent"},{"key":"key\n\t\t\t\t20170224154847_R8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2105\/AJPH.84.6.890","article-title":"The urgent need for a vaginal microbicide in the prevention of HIV transmission [editorial]","volume":"84","year":"1994","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t20170224154847_R9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/humupd\/5.5.506","article-title":"Prophylactic contraceptives for HIV\/AIDS","volume":"5","year":"1999","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170224154847_R10","first-page":"1356","article-title":"Boost for vaginal microbicides against HIV","volume":"341","year":"1993","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170224154847_R11","first-page":"1375","article-title":"WHO to concentrate HIV strategy on vaginal microbicide","volume":"307","year":"1993","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20170224154847_R12","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1126\/science.1699273","article-title":"Molecular targets for AIDS therapy","volume":"249","year":"1990","journal-title":"Science"},{"key":"key\n\t\t\t\t20170224154847_R13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0006-2952(00)00408-1","article-title":"Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase","volume":"60","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170224154847_R14","first-page":"119","article-title":"Inhibitors targeted at the reverse transcriptase","volume":"8","year":"1992","journal-title":"J Acquir Immune Defic Syndr Res Human Retrovirol"},{"key":"key\n\t\t\t\t20170224154847_R15","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1073\/pnas.91.9.3911","article-title":"Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1","volume":"91","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170224154847_R16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nsb0495-293","article-title":"High resolution structures of HIV-1 RT from four RT-inhibitor complexes","volume":"2","year":"1995","journal-title":"Nat Struct Biol"},{"key":"key\n\t\t\t\t20170224154847_R17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0969-2126(01)00168-X","article-title":"Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution","volume":"3","year":"1995","journal-title":"Structure"},{"key":"key\n\t\t\t\t20170224154847_R18","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1021\/jm9707028","article-title":"Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 7. 8-Arylethyldipyridodiazepinones as potent broad-spectrum inhibitors of wild-type and mutant enzymes","volume":"41","year":"1998","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170224154847_R19","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1021\/jm960158n","article-title":"Targeting delavirdine\/atevirdine resistant HIV-1: identification of (alkylamino)piperidine-containing bis(heteroaryl)piperazines as broad spectrum HIV-1 reverse transcriptase inhibitors","volume":"39","year":"1996","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170224154847_R20","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1128\/AAC.39.12.2602","article-title":"L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase","volume":"39","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170224154847_R21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM200108093450602","article-title":"Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170224154847_R22","first-page":"S1","article-title":"HIV infection and AIDS: new biology, therapeutic advances, and clinical implications","volume":"16","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key\n\t\t\t\t20170224154847_R23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.7326\/0003-4819-124-11-199606010-00006","article-title":"Viral dynamics of HIV: implications for drug development and therapeutic strategies","volume":"124","year":"1996","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20170224154847_R24","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/00042560-199701001-00006","article-title":"Long-term therapeutic strategies in HIV","volume":"16","year":"1997","journal-title":"Immune Defic Syndr Hum Retrovirol"},{"key":"key\n\t\t\t\t20170224154847_R25","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1126\/science.1377403","article-title":"Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor","volume":"256","year":"1992","journal-title":"Science"},{"key":"key\n\t\t\t\t20170224154847_R26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0969-2126(01)00226-X","article-title":"The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design","volume":"3","year":"1995","journal-title":"Structure"},{"key":"key\n\t\t\t\t20170224154847_R27","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1128\/AAC.42.12.3225","article-title":"Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase","volume":"42","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170224154847_R28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1386-6532(01)00167-6","article-title":"Antiviral drugs: current state of the art","volume":"22","year":"2001","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20170224154847_R29","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0968-0896(98)00108-4","article-title":"Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase","volume":"6","year":"1998","journal-title":"Bioorg Med Chem"},{"key":"key\n\t\t\t\t20170224154847_R30","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0960-894X(98)00384-9","article-title":"Structure-based design of N-[2-(1-piperidinylethyl)-N\u2032-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)-N\u2032-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase","volume":"8","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170224154847_R31","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/S0960-894X(99)00460-6","article-title":"N-[2-(1-cyclohexenyl)ethyl]-N\u2032-[2-(5-bromopyridyl)]-thiourea and N\u2032-[2-(1-cyclohexenyl)ethyl]-N\u2032-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1","volume":"9","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170224154847_R32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/095632029901000502","article-title":"Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus","volume":"10","year":"1999","journal-title":"Antiviral Chem Chemother"},{"key":"key\n\t\t\t\t20170224154847_R33","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/S0960-894X(99)00624-1","article-title":"N\u2032-[2-(2-thiophene)ethyl]-N\u2032-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1","volume":"9","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170224154847_R34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/095632020001100205","article-title":"N-[2-(4-methylphenyl)ethyl]-N\u2032-[2-(5-bromopyridyl)]-thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1","volume":"11","year":"2000","journal-title":"Antiviral Chem Chemother"},{"key":"key\n\t\t\t\t20170224154847_R35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/095632020001100503","article-title":"Piperidinylethyl, phenoxyethyl and fluoroethyl bromopyridyl thiourea compounds with potent anti-HIV activity","volume":"11","year":"2000","journal-title":"Antiviral Chem Chemother"},{"key":"key\n\t\t\t\t20170224154847_R36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0960-894X(01)00011-7","article-title":"Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds","volume":"11","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170224154847_R37","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0960-894X(99)00235-8","article-title":"Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N\u2032-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus","volume":"9","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170224154847_R38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/095632020101200402","article-title":"Stereochemistry as a major determinant of the anti-HIV activity of chiral naphthyl thiourea compounds","volume":"12","year":"2001","journal-title":"Antiviral Chem Chemother"},{"key":"key\n\t\t\t\t20170224154847_R39","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0960-894X(00)00398-X","article-title":"Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase","volume":"10","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170224154847_R40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1095\/biolreprod63.1.196","article-title":"Novel thiourea compounds as dual-function microbicides","volume":"63","year":"2000","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224154847_R41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/341167a0","article-title":"Scintillation proximity assay","volume":"341","year":"1989","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170224154847_R42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0192-0561(91)90126-R","article-title":"Inhibition of HIV-1 replication in seropositive patients' CD4+ T-cells by pokeweed antiviral protein-monoclonal antibody conjugates","volume":"13","year":"1991","journal-title":"Int J Immunopharmacol"},{"key":"key\n\t\t\t\t20170224154847_R43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/347092a0","article-title":"Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies","volume":"347","year":"1990","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170224154847_R44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/AAC.42.2.383","article-title":"Langlie M-C, Myers DE. TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus","volume":"42","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170224154847_R45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1095\/biolreprod59.3.503","article-title":"Bromo-methoxy and aryl phosphate derivatives of azidothymidine are dual-function spermicides with potent anti-HIV activity","volume":"59","year":"1998","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224154847_R46","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1095\/biolreprod58.6.1515","article-title":"Spermicidal activity of metallocene complexes containing vanadium(IV) in humans","volume":"58","year":"1998","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224154847_R47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1095\/biolreprod62.1.37","article-title":"Structural requirements for potent human spermicidal activity of dual-function aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07)","volume":"62","year":"2000","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224154847_R48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0015-0282(00)01665-4","article-title":"Pokeweed antiviral protein: a potential nonspermicidal prophylactic antiviral agent","volume":"75","year":"2001","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170224154847_R49","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1095\/biolreprod60.6.1419","article-title":"Novel derivatives of phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) are dual-function spermicides with potent anti-HIV activity","volume":"60","year":"1999","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224154847_R50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1095\/biolreprod64.1.51","article-title":"Thymidine kinase-independent intracellular delivery of bioactive nucleotides by aryl phosphate derivatives of bromo-methoxy zidovudine (compounds WHI-05 and WHI-07) in normal human female genital tract epithelial cells and sperm","volume":"64","year":"2001","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224154847_R51","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00001813-200011000-00009","article-title":"Apoptosis-inducing oxovanadium(IV) complexes of 1,10-phenanthroline against human ovarian cancer","volume":"11","year":"2000","journal-title":"Anticancer Drugs"},{"key":"key\n\t\t\t\t20170224154847_R52","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/oxfordjournals.humrep.a136824","article-title":"Human and bovine cervical mucus penetration as a test of sperm function for in-vitro fertilization","volume":"3","year":"1988","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170224154847_R53","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/ci00020a020","article-title":"Application of genetic function approximation to quantitative structure activity relationships and quantitative structure property relationships","volume":"34","year":"1994","journal-title":"J Chem Inf Comp Sci"},{"key":"key\n\t\t\t\t20170224154847_R54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(00)01636-8","article-title":"Contraceptive efficacy and safety studies of a novel microemulsion-based lipophilic vaginal spermicide","volume":"75","year":"2001","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170224154847_R55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0010-7824(01)00233-5","article-title":"Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles","volume":"64","year":"2001","journal-title":"Contraception"},{"key":"key\n\t\t\t\t20170224154847_R56","doi-asserted-by":"crossref","first-page":"UNAIDS1","DOI":"10.1097\/00002030-199607000-00026","article-title":"Recommendations for the development of vaginal microbicides","volume":"10","author":"International Working Group on Vaginal Microbicides","year":"1996","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170224154847_R57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/jrf.0.0200085","article-title":"Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys","volume":"20","year":"1969","journal-title":"J Reprod Fertil"},{"key":"key\n\t\t\t\t20170224154847_R58","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1021\/jm00115a007","article-title":"Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 2","volume":"34","year":"1991","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170224154847_R59","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0960-894X(98)00249-2","article-title":"Synthesis and anti-HIV activities of urea-PETT analogs belonging to a new class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"8","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170224154847_R60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/1010-6030(92)85001-B","article-title":"Oxidation of thiourea with photochemically generated singlet oxygen","volume":"64","year":"1992","journal-title":"J Photochem Photobiol A"},{"key":"key\n\t\t\t\t20170224154847_R61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0960-894X(99)00581-8","article-title":"Antioxidant function of phenethyl-5-bromo-pyridyl thiourea compounds with potent anti-HIV activity","volume":"10","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170224154847_R62","first-page":"1","article-title":"A 13-week subchronic intravaginal toxicity study of the novel broad-spectrum anti-HIV and spermicidal agent, (N-[2-(1-cyclohexenyl)ethyl] N\u2032-[2-(5-bromopyridinyl)]-thiourea), in mice","volume":"30","year":"2002","journal-title":"Toxicol Pathol"},{"key":"key\n\t\t\t\t20170224154847_R63","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1023\/A:1014814313681","article-title":"Evaluation of the pharmacokinetic features and tissue distribution of the potent nonnucleoside inhibitor of HIV-1 reverse transcriptase, N-[2-(2-fluorophenethyl)]-N\u2032-[2-(5-bromopyridyl)]-thiourea (HI-240) with an analytical HPLC method","volume":"16","year":"1999","journal-title":"Pharmacol Res"},{"key":"key\n\t\t\t\t20170224154847_R64","first-page":"574","article-title":"In vivo toxicity, pharmacokinetic features and tissue distribution of N-[2-(2,5-dimethoxyphenylethyl)]-N\u2032-[2-(5-bromopyridyl)]-thiourea (HI-236), a potent non-nucleoside inhibitor of HIV-1 reverse transcriptase","volume":"51","year":"2001","journal-title":"Drug Res"},{"key":"key\n\t\t\t\t20170224154847_R65","first-page":"A02","article-title":"Study finds drug-resistant HIV in half of infected patients. Washington Post News Report","year":"2001"},{"key":"key\n\t\t\t\t20170224154847_R66","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(02)07249-5","article-title":"Many HIV patients carry mutated drug-resistant strains","volume":"359","year":"2002","journal-title":"Lancet"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biolreprod\/article-pdf\/67\/6\/1959\/10560861\/biolreprod1959.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T18:47:09Z","timestamp":1624733229000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-lookup\/doi\/10.1095\/biolreprod.102.006478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,1]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12,1]]}},"URL":"https:\/\/doi.org\/10.1095\/biolreprod.102.006478","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,1]]}}}